Table 2.
Microbial profile in the patients' groups
|
|
EOS group (n = 30)
|
LOS group (n = 30)
|
Total (n =60)
|
t
|
P
value
|
|
| Gram-negative bacteria | Total | 21 (70.0%) | 28 (93.3%) | 49 (81.67%) | 2.3 | < 0.01 |
| Klebsiella | 15 (50%) | 20 (67%) | 35 (58%) | 1.3 | NS | |
| E. coli | 4 (13.30%) | 1 (3.3%) | 5 (8.33%) | -1.4 | NS | |
| Acinetobacter | 2 (6.66%) | 4 (13.30%) | 6 (10%) | 0.85 | NS | |
| Serratia | 0% | 1 (3.3%) | 1 (1.66%) | |||
| Pseudomonas | 0% | 2 (6.66%) | 2 (3.33%) | |||
| Gram-positive bacteria | Total | 8 (26.7%) | 2 (6.7%) | 10 (16.7%) | -2.07 | < 0.01 |
| Group B Streptococcus | 5 (16.60%) | 0% | 5 (8.33%) | |||
| CoNS | 2 (6.66%) | 1 (3.3%) | 3 (5%) | -0.6 | NS | |
| Enterococcus | 1 (3.3%) | 0% | 1 (1.66%) | |||
| MRSA | 0% | 1 (3.3%) | 1 (1.66%) | |||
| Candida | 1 (3.3%) | 0% | 1 (1.66%) | |||
EOS: Early-onset sepsis; LOS: Late-onset sepsis; E. coli: Escherichia coli; CoNS: Coagulase-negative staphylococci; MRSA: Methicillin-resistant Staphylococcus aureus; NS: Not significant.